FcγRIII stimulation breaks the tolerance of human nasal epithelial cells to bacteria through cross-talk with TLR4

Publication date

2019-03-01

Authors

Golebski, K.
Hoepel, W.
van Egmond, D.
de Groot, E. J.
Amatngalim, Gimano DORCID 0000-0003-3442-1754
Beekman, JMISNI 0000000388915338
Fokkens, W. J.
van Drunen, C. M.
den Dunnen, J.

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

The nasal cavity displays immune tolerance to commensal bacteria under homeostatic conditions, which is rapidly converted to a pro-inflammatory response upon infection. Yet, the factors that control this conversion are still largely unknown. Here, we provide evidence that Fc gamma receptor III (FcγRIII) stimulation breaks immune tolerance to bacteria in the human nasal cavity through activation of nasal epithelial cells, which are the first line of defense against invading microbes. While under steady-state conditions human nasal epithelial cells were completely non-responsive to Gram-negative bacteria P. aeruginosa or TLR4 ligand LPS, IgG opsonization of bacteria, as occurs upon infection, strongly induced production of pro-inflammatory agents such as IL-6 and IL-8. This breaking of tolerance to bacteria was completely dependent on FcγRIII, which amplified cytokine gene transcription through cross-talk with TLR4. In addition, we identified that epithelial cells from patients suffering from chronic rhinosinusitis with nasal polyps do not display LPS tolerance, thereby providing an explanation for the disturbed host defense responses of these patients. Taken together, these data are the first to identify FcγR expression on nasal epithelial cells, as well as to identify its important role in controlling the balance between tolerance and inflammation in the nasal cavity.

Keywords

Immunology and Allergy, Immunology

Citation

Golebski, K, Hoepel, W, van Egmond, D, de Groot, E J, Amatngalim, G D, Beekman, J M, Fokkens, W J, van Drunen, C M & den Dunnen, J 2019, 'FcγRIII stimulation breaks the tolerance of human nasal epithelial cells to bacteria through cross-talk with TLR4', Mucosal immunology, vol. 12, no. 2, pp. 425-433. https://doi.org/10.1038/s41385-018-0129-x